Rechercher dans ce blog

Friday, January 10, 2020

Here's Why Edwards Lifesciences Stock Rose 52.3% in 2019 - The Motley Fool

What happened

Shares of Edwards Lifesciences (NYSE:EW) soared over 52% last year, according to data provided by S&P Global Market Intelligence. The company, which specializes in medical devices used to address structural heart disease, delivered impressive revenue gains and steadily improved full-year 2019 guidance with each quarterly update. That allowed the growth stock to easily beat the 28.8% rise of the S&P 500 in 2019.

Management believes growth should continue for the foreseeable future. As of December, Edwards Lifesciences expected to reach the top end of its full-year 2019 revenue guidance range of $4 billion to $4.3 billion. The company sees revenue increasing 10% to 12% in 2020. 

An arrow jumping up shelves on a wall.

Image source: Getty Images.

So what

In the first nine months of 2019, Edwards Lifesciences grew revenue 15.6% compared to the year-ago period. Operating income rose only 10% in that span, primarily due to a 22% increase in research and development expenses. The company is investing heavily in the future as it races to capture an expected $10 billion opportunity in transcatheter valve therapy by 2024. 

So far, so good. Edwards Lifesciences generated $700 million in revenue from its transcatheter aortic valve replacement (TAVR) portfolio in Q3 of 2019, which represented 64% of total revenue during the period and marked a 26% increase compared to the year-ago quarter. 

Now what

Edwards Lifesciences is now valued at $49 billion -- nearly double its market valuation from the beginning of 2018. On the one hand, the business operates in a high-margin niche with relatively large obstacles to entry. On the other hand, the stock is valued at 38 times forward earnings. While the S&P 500 is trading at a historic premium as well, investors might not be too surprised to see shares cool off if the broader economy slows. 

Let's block ads! (Why?)



"Here" - Google News
January 10, 2020 at 10:41PM
https://ift.tt/30aT1sB

Here's Why Edwards Lifesciences Stock Rose 52.3% in 2019 - The Motley Fool
"Here" - Google News
https://ift.tt/39D7kKR
Shoes Man Tutorial
Pos News Update
Meme Update
Korean Entertainment News
Japan News Update

No comments:

Post a Comment

Search

Featured Post

A New Cafe, Cocktail Bar, Sports Pub, and Pickleball Destination Is Opening in Far South Austin - Eater Austin

takanadalagi.blogspot.com Two new sibling bars are opening in far south Austin sometime this year. There’s cafe and cocktail bar Drifters S...

Postingan Populer